- Discoverability Visible
- Join Policy Invite Only
- Created 21 Jan 2022
About the Group
Public Description
This is a collaboration space for the NCI and NIBIB’s SynBio and Cancer Program. Research teams use synthetic biology technologies to address challenges across cancer biology, prevention, early detection, diagnosis, and treatment.
Teams applied through the following announcement- https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-054.html
| Projects Awarded | ||
| PI Name(s) | Institution(s) | Project Title |
| Gabriel Kwong, Peng Qiu | Georgia Tech | AND-gated Synthetic Biomarkers for Early Detection of Liver Metastasis |
| Wendell Lim, Hana El-Samad | University of California at San Francisco | Synthetic circuits that drive infiltration of therapeutic T cells into immunologically cold tumors |
| Justin Pritchard | Penn State | Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer |
| Ron Weiss, Yizhou Dong, Darrell Irvine | Massachusetts Institute of Technology, Ohio State | Immunotherapy via engineered therapeutic programs in tumors using RNA |
| Wilson Wong, Yolonda Colson, Mark Grinstaff | Boston University, Mass General | Precise tumor targeting with logic CAR circuits |
| Amir Zarrinpar | University of California, San Diego | Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer |
NIH Program Contacts:
NCI:
Michelle Berny-Lang
E-mail: michelle.berny-lang@nih.gov
NIBIB:
Dave Rampulla
E-mail: david.rampulla@nih.gov
Comments
There are no comments on this entry.